The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasukawa, M.
Right arrow Articles by Kobayashi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasukawa, M.
Right arrow Articles by Kobayashi, Y.

The Journal of Immunology, Vol 140, Issue 10 3419-3425, Copyright © 1988 by American Association of Immunologists


ARTICLES

Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus

M Yasukawa, A Inatsuki and Y Kobayashi
First Department of Internal Medicine, Ehime University School of Medicine, Japan.

Three HSV type 1 (HSV-1) and HSV type 2 (HSV-2) common ("HSV-type common") and three HSV-1 specific CTL clones, which were CD3+, CD4+, CD8-, 4B4+, and 2H4-, were established. These clones proliferated in response to stimulation with HSV in the presence of autologous APC. The HSV type specificity of the proliferative response was identical with that of the cytotoxic activity of the clones. The cytotoxic activity and the proliferative response were both inhibited by addition of anti- HLA-DR mAb to the culture. After culture of these CTL clones with autologous B cells and macrophages followed by HSV Ag stimulation, anti- HSV antibody was detected in the culture supernatant. The HSV type specificity of the helper function for antibody production was identical with that of the cytotoxicity, i.e., HSV-type common clones, upon stimulation with either HSV-1, or HSV-2, and HSV-1-specific clones, upon stimulation with HSV-1 but not with HSV-2, showed helper activity for anti-HSV antibody production by autologous B cells. Moreover, it was found that these clones produced humoral factors which help autologous B cells to produce antibody. The helper factors were produced by T cell clones in an HSV-type-specific manner. These data suggest that some CD4+ T cells can simultaneously manifest both specific cytotoxicity and helper activity for Ag-specific antibody production by B cells, and that these multifunctional T cells might play an important role in protection against viral infection.


This article has been cited by other articles:


Home page
BloodHome page
Y. Guo, H. Niiya, T. Azuma, N. Uchida, Y. Yakushijin, I. Sakai, T. Hato, M. Takahashi, S. Senju, Y. Nishimura, et al.
Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner
Blood, August 15, 2005; 106(4): 1415 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Azuma, T. Otsuki, K. Kuzushima, C. J. Froelich, S. Fujita, and M. Yasukawa
Myeloma Cells Are Highly Sensitive to the Granule Exocytosis Pathway Mediated by WT1-Specific Cytotoxic T Lymphocytes
Clin. Cancer Res., November 1, 2004; 10(21): 7402 - 7412.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. BenMohamed, G. Bertrand, C. D. McNamara, H. Gras-Masse, J. Hammer, S. L. Wechsler, and A. B. Nesburn
Identification of Novel Immunodominant CD4+ Th1-Type T-Cell Peptide Epitopes from Herpes Simplex Virus Glycoprotein D That Confer Protective Immunity
J. Virol., September 1, 2003; 77(17): 9463 - 9473.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Yanai, E. Ishii, K. Kojima, A. Hasegawa, T. Azuma, S. Hirose, N. Suga, A. Mitsudome, M. Zaitsu, Y. Ishida, et al.
Essential Roles of Perforin in Antigen-Specific Cytotoxicity Mediated by Human CD4+ T Lymphocytes: Analysis Using the Combination of Hereditary Perforin-Deficient Effector Cells and Fas-Deficient Target Cells
J. Immunol., February 15, 2003; 170(4): 2205 - 2213.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
D. M. Koelle and L. Corey
Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research
Clin. Microbiol. Rev., January 1, 2003; 16(1): 96 - 113.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Makita, A. Hiraki, T. Azuma, A. Tsuboi, Y. Oka, H. Sugiyama, S. Fujita, M. Tanimoto, M. Harada, and M. Yasukawa
Antilung Cancer Effect of WT1-specific Cytotoxic T Lymphocytes
Clin. Cancer Res., August 1, 2002; 8(8): 2626 - 2631.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. A. Brockman and D. M. Knipe
Herpes Simplex Virus Vectors Elicit Durable Immune Responses in the Presence of Preexisting Host Immunity
J. Virol., March 19, 2002; 76(8): 3678 - 3687.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Cao, P. Meuleman, I. Desombere, M. Sallberg, and G. Leroux-Roels
In Vivo Inhibition of Anti-Hepatitis B Virus Core Antigen (HBcAg) Immunoglobulin G Production by HBcAg-Specific CD4+ Th1-Type T-Cell Clones in a hu-PBL-NOD/SCID Mouse Model
J. Virol., December 1, 2001; 75(23): 11449 - 11456.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
P. P. Heinen, E. A. de Boer-Luijtze, and A. T. J. Bianchi
Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection
J. Gen. Virol., November 1, 2001; 82(11): 2697 - 2707.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. M. Koelle, M. Schomogyi, C. McClurkan, S. N. Reymond, and H. B. Chen
CD4 T-Cell Responses to Herpes Simplex Virus Type 2 Major Capsid Protein VP5: Comparison with Responses to Tegument and Envelope Glycoproteins
J. Virol., December 1, 2000; 74(23): 11422 - 11425.
[Abstract] [Full Text]


Home page
BloodHome page
M. Yasukawa, H. Ohminami, J. Arai, Y. Kasahara, Y. Ishida, and S. Fujita
Granule exocytosis, and not the Fas/Fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4+ as well as CD8+ cytotoxic T lymphocytes in humans
Blood, April 1, 2000; 95(7): 2352 - 2355.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Yasukawa, H. Ohminami, Y. Yakushijin, J. Arai, A. Hasegawa, Y. Ishida, and S. Fujita
Fas-Independent Cytotoxicity Mediated by Human CD4+ CTL Directed Against Herpes Simplex Virus-Infected Cells
J. Immunol., May 15, 1999; 162(10): 6100 - 6106.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Saito, K. Haruta, M. Shimuta, H. Inoue, H. Sakurai, K. Yamada, N. Ishimaru, H. Higashiyama, T. Sumida, H. Ishida, et al.
Fas Ligand-Mediated Exocrinopathy Resembling Sjogren's Syndrome in Mice Transgenic for IL-10
J. Immunol., March 1, 1999; 162(5): 2488 - 2494.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Ohminami, M. Yasukawa, S. Kaneko, Y. Yakushijin, Y. Abe, Y. Kasahara, Y. Ishida, and S. Fujita
Fas-Independent and Nonapoptotic Cytotoxicity Mediated by a Human CD4+ T-Cell Clone Directed Against an Acute Myelogenous Leukemia-Associated DEK-CAN Fusion Peptide
Blood, February 1, 1999; 93(3): 925 - 935.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. M. Posavad, D. M. Koelle, M. F. Shaughnessy, and L. Corey
Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses
PNAS, September 16, 1997; 94(19): 10289 - 10294.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Nakao, A. Takami, H. Takamatsu, W. Zeng, N. Sugimori, H. Yamazaki, Y. Miura, M. Ueda, S. Shiobara, T. Yoshioka, et al.
Isolation of a T-Cell Clone Showing HLA-DRB1*0405-Restricted Cytotoxicity for Hematopoietic Cells in a Patient With Aplastic Anemia
Blood, May 15, 1997; 89(10): 3691 - 3699.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.